SlideShare a Scribd company logo
3Q05 Results
Disclaimer

 This presentation contains certain statements that are neither reported financial results
 or other historical information. They are forward-looking statements.


 Because these forward-looking statements are subject to risks and uncertainties,
 actual future results may differ materially from those expressed in or implied by the
 statements. Many of these risks and uncertainties relate to factors that are beyond
 CCR’s ability to control or estimate precisely, such as future market conditions,
 currency fluctuations, the behavior of other market participants, the actions of
 governmental regulators, the Company's ability to continue to obtain sufficient
 financing to meet its liquidity needs; and changes in the political, social and regulatory
 framework in which the Company operates or in economic or technological trends or
 conditions, inflation and consumer confidence, on a global, regional or national basis.


 Readers are cautioned not to place undue reliance on these forward-looking
 statements, which speak only as of the date of this document. CCR does not
 undertake any obligation to publicly release any revisions to these forward looking
 statements to reflect events or circumstances after the date of these

                                            2
Agenda


   Highlights


   Results


   Outlook




                3
Highlights




    4
Highlights




 Operating
  • Lower operating costs with higher margins




 Reversal
  • Reversal of fiscal contingencies provision of R$ 62.1 million




                                      5
Escolher Novos Caminhos
       Vencer Novos Desafios
          São Paulo, 18 de Novembro de 2005




                         6
Choosing New Paths
       Winning New Challenges
           São Paulo, November 18, 2005




                       7
Results




  8
3Q05 Results




  R$ Million                      3Q05          3Q04      Ch%    3Q05 e/VO     Ch %
  Net Revenues                   519.3         393.0     32.1%     432.3      10.0%
  Total Costs                   (290.4)       (235.0)    23.6%    (240.1)      2.2%
  EBIT                           228.9         158.0     44.9%     192.2      21.7%
     EBIT Margin                44.1%         40.2%     +3.9p.p.  44.5%      +4.3p.p.
  Depreciation & Amortization    81.3           57.9     40.4%     59.8        3.3%
  EBITDA                         310.2         215.9     43.7%     252.0      16.7%
     EBITDA Margin              59.7%          54.9%     +4.8p.p  58.3%       +3.4p.p
  Financial Result               47.9          (18.5)   -359.4%    15.7      -184.9%
  Net Income                     182.3         93.6      94.8%     137.1      46.5%




            ViaOeste, operations management and currency exchange
                               determined one more excellent quarter.
                                          9
9M05 Results




  R$ Million                   9M05      9M04      ch %    9M05 eVO ch%
  Net Revenues                1,402.4   1,065.3    31.6%    1,211.3  13.7%
  Total Costs                 (830.3)   (694.2)    19.6%    (722.6)  4.1%
  EBIT                         572.1     371.1     54.1%     488.7   31.7%
     EBIT Margin               40.8%     34.8%    +6.0p.p.  40.3%   +5.5p.p.
  Depreciation & Amortization 221.1      169.7     30.3%     178,2   5.0%
  EBITDA                       793.2     540.8     46.7%     666.9   23.3%
     EBITDA Margin             56.6%     50.8%    +5.8p.p.  55.0%   +4.2p.p
  Financial Result             (24.9)   (124.6)   -80.0%     (13.7) -89.0%
  Net Income                   347.9     166.0    109.5%     314.1   89.2%




           The same efficiency can be noticed in this first half results.
                                        10
Revenues

   Toll Revenues     (R$ 000)                     3Q05      3Q04       Ch(%)       9M05        9M04         Ch(%)
   Total                                        538,691   405,975      32.7%     1,454,976   1,100,324      32.2%
   % Total Revenues                              96.4%     96.3%                   96.4%       96.5%
   Other Revenues                                 3Q05      3Q04       var(%)      9M05        9M04         var(%)
   Total                                        14,771     10,362      42.5%      38,959       28,340       37.5%
   % Total Revenues                              2,6%       2,5%                   2,6%         2,5%
   Revenues from Payment Systems                 3Q05       3Q04       var(%)      9M05        9M04         var(%)
   STP                                           5.538     5.070        9.2%      14.924       12.157       22.8%
   % Total Revenues                              1.0%       1.2%                   1.0%         1.1%
   Total                                        559,000   421,407      32.7%     1,508,859   1,140,821      32.3%




         Revenues Breakdown 2Q05                                          Toll Payment Methods
         ViaOeste


  Via Lagos          17%                                  Electronic            35,6%                    43,1%
                                      AutoBAn
    Ponte     4%                40%                        Cash


              11%
 Rodonorte
                                                                                64,4%                    56,9%
                       26%


                    NovaDutra                                                   3Q04                     3Q05



                                                   11
Traffic

Quarterly Evolution                                               3Q05 x 3Q04 – Evolution by Each Concession
(Vehicle Equivalents – million)


                                                 CCR: +19.6%
                                                 E/VO: - 0.6%


                                           77
                                    65
               60           60            64
  55


                                                                                      5.1%
                                                                                                                   4.1%
                                                                  3.8%


                                                                          NovaDutra            RodoNorte   Ponte

 3T01        3T02          3T03    3T04   3T05                  AutoBAn             ViaLagos               -0.5% ViaOeste
                                                                            -1.5%




                                                                                                 -7.0%


                                  Despite a high interest rates scenario, the business
                                                           remained strong and solid.
                                                         12
Traffic

Nine Months Historical Evolution                                9M05 x 9M04 – Evolution by Each Concession
(Vehicle Equivalents – million)




                                          220    CCR: +18,2%
                                                 E/VO: +2,0%
                                    186   190
              169          171
 159                                                           8.1%             8.1%




                                                                       0.5%              Rodonorte   Ponte

                                                            AutoBAn NovaDutra ViaLagos
                                                                                                     -1.5%
 9M01        9M02         9M03     9M04   9M05
                                                                                           -4.0%




                                  Despite a high interest rates scenario, the business
                                                           remained strong and solid.
                                                       13
Total Costs


                 Total Costs as a % of Net Revenues Evolution


         59,8%             55,9%                        65,2%                         59,2%
         13%                16%                          12%                          15%
         10%                                             11%
                            12%                                                       13%
         21%                                             21%
                            23%                                                       22%

         33%                23%                          33%                          24%


         24%                27%                          24%                          26%


         3Q04              3Q05                         9M04                         9M05

          D&A        Concession Costs               Third Party services             Payroll   Other


                            Total Costs = Cost of Services plus Administrative Expenses




                 Operating efficiency will be focused by the Company
                                               14
Indebtedness




                             Gross                                                     Net
                                           1,467.4
                1,268.7
                              1,184.1                                                                1,213.6
                                            80.5%
                                                                           873.7




                                                            R$ (million)
 R$ (million)




                               69.3%
                                                                                       678.5
                56.6%

                                                                           1,62
                                                                                       1,05           1,20


                3Q03           3Q04         3Q05                           3Q03        3Q04          3Q05

                Short Term   Long Term        In R$                         Net Debt      Net Debt / EBITDA




                                      Low leverage gives flexibility for a new growth step
                                                       15
Indebtedness




                 Source of Funding                                                   Long Term Debt Amortization

                     Other
                   (102.8% CDI)                                                      415.6
                                        BID / IFC
                                        (Libor + 4.5%)
    Debentures          13%
                                  19%                                                        254.7
    (105% CDI)                                                                                       209.1
                   10%                                                                                       181.2




                                                         R$ (million)
                                                                                                                       88.1
                       22%                                                   48.9
                                  36%
     Debêntures
(IGP-M + 9.5% - 11%)                                                      2006       2007    2008    2009    2010    After 2010
                                      BNDES                             (3 months)
                                    (TJLP + 5.0%)




                                        Diversified sources, long term and no maturity
                                                                        concentration.
                                                                        16
Capital Expenditures




         CAPEX (R$ MM)                    1Q05          2Q05          3Q05        2005 (E) 2006(E)
         AutoBAn                          6.9           18.0          33.1         168.6    178.6
         NovaDutra                        16.4          17.8          22.1         110.1     83.7
         Rodonorte                        3,7            9,9          23,9          53,5     10,3
         Ponte                            0.7            2.0           1.8          22.8     11.0
         Via Lagos                        0.1            0.3           1.7          10.6     2.8
         ViaOeste                         3.3           21.2          27.3          90.0     90.0
               1
         Other                            0.7           1.2            0.9          16.9     17.5
         Consolidated                     31.9          70.4          110.8        472.5    393.9


  Note: Fiscal Year 2005 (E) and 2006 (E) includes inflation adjustment of 8.0% and 7.0% respectively
   1- Includes CCR, Actua, Engelog and STP.



                      Foreseeability, a business distinguishing mark. Capital
                                expenditures are clearly defined in contract.
                                                         17
Outlook




  18
New Businesses



   New Federal Concessions

   New Concessions in the State of São Paulo

   Porto Alegre Metropolitan Pole

   Mexico

   Chile



            Brazil continues the main growth driver. However, CCR
                                         will look for other markets
                                19
Investor Relations


  Ricardo Froes - CFO
  ricardo.froes@ccrnet.com.br
  Phone: 55 (11) 3048-5921

  Arthur Piotto Filho - IR
  arthur.piotto@ccrnet.com.br
  Phone: 55 (11) 3048-5932

       BOVESPA: CCRO3
   Bloomberg: CCRO3 BZ
      Reuters: CCRO3.SA


  www.ccrnet.com.br       invest@ccrnet.com.br

                                 20
3Q05 Results

More Related Content

What's hot

Maybank - proposed dividend reinvestment plan EGM 14 may 2010
Maybank - proposed dividend reinvestment plan EGM 14 may 2010Maybank - proposed dividend reinvestment plan EGM 14 may 2010
Maybank - proposed dividend reinvestment plan EGM 14 may 2010
guest6398289
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
04 30 2009 I First Quarter Results 2009 Usgaap
04 30 2009 I First Quarter Results 2009   Usgaap04 30 2009 I First Quarter Results 2009   Usgaap
04 30 2009 I First Quarter Results 2009 UsgaapEmbraer RI
 
capital onePrinter Friendly Version of the Conference Call Presentation
capital onePrinter Friendly Version of the Conference Call Presentationcapital onePrinter Friendly Version of the Conference Call Presentation
capital onePrinter Friendly Version of the Conference Call Presentationfinance13
 
4 q10 presentation
4 q10 presentation4 q10 presentation
4 q10 presentationEquatorial
 
Apresentação call 2 t12_eng
Apresentação call 2 t12_engApresentação call 2 t12_eng
Apresentação call 2 t12_engArteris S.A.
 
MTM IX - Accounting Management Project Work
MTM IX - Accounting Management Project Work MTM IX - Accounting Management Project Work
MTM IX - Accounting Management Project Work MTM IULM
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10Profarma
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10Profarma
 
3Q11 Presentation
3Q11 Presentation3Q11 Presentation
3Q11 PresentationGafisa RI !
 
VIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 ResultsVIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Investor Relations
 

What's hot (18)

Maybank - proposed dividend reinvestment plan EGM 14 may 2010
Maybank - proposed dividend reinvestment plan EGM 14 may 2010Maybank - proposed dividend reinvestment plan EGM 14 may 2010
Maybank - proposed dividend reinvestment plan EGM 14 may 2010
 
Presentation 3Q12
Presentation 3Q12Presentation 3Q12
Presentation 3Q12
 
Presentation 2Q12
Presentation 2Q12Presentation 2Q12
Presentation 2Q12
 
Investors' Meeting - 1Q09 Results
Investors' Meeting - 1Q09 ResultsInvestors' Meeting - 1Q09 Results
Investors' Meeting - 1Q09 Results
 
04 30 2009 I First Quarter Results 2009 Usgaap
04 30 2009 I First Quarter Results 2009   Usgaap04 30 2009 I First Quarter Results 2009   Usgaap
04 30 2009 I First Quarter Results 2009 Usgaap
 
Webcast 3Q09
Webcast 3Q09Webcast 3Q09
Webcast 3Q09
 
capital onePrinter Friendly Version of the Conference Call Presentation
capital onePrinter Friendly Version of the Conference Call Presentationcapital onePrinter Friendly Version of the Conference Call Presentation
capital onePrinter Friendly Version of the Conference Call Presentation
 
4 q10 presentation
4 q10 presentation4 q10 presentation
4 q10 presentation
 
Apimec – 1 q07 results
Apimec – 1 q07 resultsApimec – 1 q07 results
Apimec – 1 q07 results
 
Apimec 2 q06 results
Apimec   2 q06 resultsApimec   2 q06 results
Apimec 2 q06 results
 
Piaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial ResultsPiaggio Group - First Nine Months 2011 Financial Results
Piaggio Group - First Nine Months 2011 Financial Results
 
Apresentação call 2 t12_eng
Apresentação call 2 t12_engApresentação call 2 t12_eng
Apresentação call 2 t12_eng
 
MTM IX - Accounting Management Project Work
MTM IX - Accounting Management Project Work MTM IX - Accounting Management Project Work
MTM IX - Accounting Management Project Work
 
Banco Sabadell FY10 Results
Banco Sabadell FY10 ResultsBanco Sabadell FY10 Results
Banco Sabadell FY10 Results
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10
 
Profarma 4Q10
Profarma 4Q10Profarma 4Q10
Profarma 4Q10
 
3Q11 Presentation
3Q11 Presentation3Q11 Presentation
3Q11 Presentation
 
VIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 ResultsVIVO - Apresentation of 1st Quarter 2008 Results
VIVO - Apresentation of 1st Quarter 2008 Results
 

Viewers also liked

State of são paulo metropolitan secretariat presentation – jurandir fernandes
State of são paulo metropolitan secretariat presentation – jurandir fernandesState of são paulo metropolitan secretariat presentation – jurandir fernandes
State of são paulo metropolitan secretariat presentation – jurandir fernandesCCR Relações com Investidores
 
Presentation 2Q13
Presentation 2Q13Presentation 2Q13
Presentation CCR DAY 9
Presentation CCR DAY 9Presentation CCR DAY 9
Presentation CCR DAY 9
CCR Relações com Investidores
 
Presentation 1Q13
Presentation 1Q13Presentation 1Q13
Apresentação 4T15 CCR
Apresentação 4T15 CCRApresentação 4T15 CCR
Apresentação 4T15 CCR
CCR Relações com Investidores
 

Viewers also liked (17)

Ccr day presentation
Ccr day presentationCcr day presentation
Ccr day presentation
 
C:\fakepath\2 q10 apresentação-english
C:\fakepath\2 q10   apresentação-englishC:\fakepath\2 q10   apresentação-english
C:\fakepath\2 q10 apresentação-english
 
Apimec – 2 q07 results
Apimec – 2 q07 resultsApimec – 2 q07 results
Apimec – 2 q07 results
 
State of são paulo metropolitan secretariat presentation – jurandir fernandes
State of são paulo metropolitan secretariat presentation – jurandir fernandesState of são paulo metropolitan secretariat presentation – jurandir fernandes
State of são paulo metropolitan secretariat presentation – jurandir fernandes
 
Presentation 2Q13
Presentation 2Q13Presentation 2Q13
Presentation 2Q13
 
Ubs warburg 2003 brazil ceo conference
Ubs warburg 2003 brazil ceo conferenceUbs warburg 2003 brazil ceo conference
Ubs warburg 2003 brazil ceo conference
 
Presentation 4Q12
Presentation 4Q12Presentation 4Q12
Presentation 4Q12
 
Ubs warburg conferência ceo brasil 2003
Ubs warburg conferência ceo brasil 2003Ubs warburg conferência ceo brasil 2003
Ubs warburg conferência ceo brasil 2003
 
3 q02 earnings results
3 q02 earnings results3 q02 earnings results
3 q02 earnings results
 
Presentation CCR DAY 9
Presentation CCR DAY 9Presentation CCR DAY 9
Presentation CCR DAY 9
 
Presentation CCR - 3Q09
Presentation CCR - 3Q09Presentation CCR - 3Q09
Presentation CCR - 3Q09
 
Apimec 4 q04 results
Apimec   4 q04 resultsApimec   4 q04 results
Apimec 4 q04 results
 
1 q06 earnings conference call transcription
1 q06 earnings conference call transcription1 q06 earnings conference call transcription
1 q06 earnings conference call transcription
 
Presentation 1Q13
Presentation 1Q13Presentation 1Q13
Presentation 1Q13
 
Apimec – 4 q07 results
Apimec – 4 q07 resultsApimec – 4 q07 results
Apimec – 4 q07 results
 
Ring road concession conference call
Ring road concession conference callRing road concession conference call
Ring road concession conference call
 
Apresentação 4T15 CCR
Apresentação 4T15 CCRApresentação 4T15 CCR
Apresentação 4T15 CCR
 

Similar to Apimec 3 q05 results

Apres call 2_q10_v2
Apres call 2_q10_v2Apres call 2_q10_v2
Apres call 2_q10_v2Arteris S.A.
 
3 conference call 2 q10
3   conference call 2 q103   conference call 2 q10
3 conference call 2 q10Arteris S.A.
 
Call presentation 4 q11_eng
Call presentation 4 q11_engCall presentation 4 q11_eng
Call presentation 4 q11_engArteris S.A.
 
Apresentação call 3 t12_eng
Apresentação call 3 t12_engApresentação call 3 t12_eng
Apresentação call 3 t12_engArteris S.A.
 
ApresentaçãO 1 Q07
ApresentaçãO 1 Q07ApresentaçãO 1 Q07
ApresentaçãO 1 Q07Localiza
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08Profarma
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationProfarma
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Engprofarma1
 
3Q06 Results Presentation
3Q06 Results Presentation3Q06 Results Presentation
3Q06 Results PresentationProfarma
 
3 q10 final
3 q10 final3 q10 final
3 q10 finalLocaliza
 
Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208finance38
 
2009 - First Quarter Results 2009 Usgaap
2009 - First Quarter Results 2009   Usgaap2009 - First Quarter Results 2009   Usgaap
2009 - First Quarter Results 2009 UsgaapEmbraer RI
 

Similar to Apimec 3 q05 results (20)

Ccr day 4 presentation
Ccr day 4 presentationCcr day 4 presentation
Ccr day 4 presentation
 
Apres call 2_q10_v2
Apres call 2_q10_v2Apres call 2_q10_v2
Apres call 2_q10_v2
 
3 conference call 2 q10
3   conference call 2 q103   conference call 2 q10
3 conference call 2 q10
 
Q2 2011 financial_highlights
Q2 2011 financial_highlightsQ2 2011 financial_highlights
Q2 2011 financial_highlights
 
Presentation 4Q11
Presentation 4Q11Presentation 4Q11
Presentation 4Q11
 
Call presentation 4 q11_eng
Call presentation 4 q11_engCall presentation 4 q11_eng
Call presentation 4 q11_eng
 
Apresentação call 3 t12_eng
Apresentação call 3 t12_engApresentação call 3 t12_eng
Apresentação call 3 t12_eng
 
ApresentaçãO 1 Q07
ApresentaçãO 1 Q07ApresentaçãO 1 Q07
ApresentaçãO 1 Q07
 
Investors' Meeting Presentation - 4Q09 Results
Investors' Meeting Presentation - 4Q09 ResultsInvestors' Meeting Presentation - 4Q09 Results
Investors' Meeting Presentation - 4Q09 Results
 
Earnings Release 3 Q08
Earnings Release 3 Q08Earnings Release 3 Q08
Earnings Release 3 Q08
 
Earnings Release 3Q08 Presentation
Earnings Release 3Q08 PresentationEarnings Release 3Q08 Presentation
Earnings Release 3Q08 Presentation
 
Investors meeting 1 q08 results
Investors meeting   1 q08 resultsInvestors meeting   1 q08 results
Investors meeting 1 q08 results
 
Profarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 EngProfarma Apresentacao 3 Q08 20081105 Eng
Profarma Apresentacao 3 Q08 20081105 Eng
 
4Q12 Presentation
4Q12 Presentation4Q12 Presentation
4Q12 Presentation
 
3Q06 Results Presentation
3Q06 Results Presentation3Q06 Results Presentation
3Q06 Results Presentation
 
3 q10 final
3 q10 final3 q10 final
3 q10 final
 
Investors' meeting 2 q08 results
Investors' meeting   2 q08 resultsInvestors' meeting   2 q08 results
Investors' meeting 2 q08 results
 
Apimec 4 q06 results
Apimec   4 q06 resultsApimec   4 q06 results
Apimec 4 q06 results
 
Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208Operating_Results_Q106_to_Q208
Operating_Results_Q106_to_Q208
 
2009 - First Quarter Results 2009 Usgaap
2009 - First Quarter Results 2009   Usgaap2009 - First Quarter Results 2009   Usgaap
2009 - First Quarter Results 2009 Usgaap
 

More from CCR Relações com Investidores

CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18
CCR Relações com Investidores
 
Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18
CCR Relações com Investidores
 
Apresentação 2T18
Apresentação 2T18Apresentação 2T18
Apresentação 2T18
CCR Relações com Investidores
 
2Q18 Presentation
2Q18 Presentation2Q18 Presentation
1Q18 Presentation
1Q18 Presentation1Q18 Presentation
Apresentação 1T18
Apresentação 1T18Apresentação 1T18
Apresentação 1T18
CCR Relações com Investidores
 
4Q17 Earnings Presentation
4Q17 Earnings Presentation4Q17 Earnings Presentation
4Q17 Earnings Presentation
CCR Relações com Investidores
 
Apresentação 4T17
Apresentação 4T17Apresentação 4T17
Apresentação 4T17
CCR Relações com Investidores
 
CCR Day 13 Presentation
CCR Day 13 Presentation CCR Day 13 Presentation
CCR Day 13 Presentation
CCR Relações com Investidores
 
CCR Day 13
CCR Day 13 CCR Day 13
Presentation 3Q17
Presentation 3Q17  Presentation 3Q17
Apresentação 3T17
Apresentação 3T17Apresentação 3T17
Apresentação 3T17
CCR Relações com Investidores
 
Presentations 2Q17
Presentations 2Q17Presentations 2Q17
Apresentação 2T17
Apresentação 2T17Apresentação 2T17
Apresentação 2T17
CCR Relações com Investidores
 
Presentation 2Q17
Presentation 2Q17Presentation 2Q17
Apresentação 2 t17
Apresentação 2 t17Apresentação 2 t17
Apresentação 2 t17
CCR Relações com Investidores
 
Presentation 1Q17
Presentation 1Q17 Presentation 1Q17
Apresentação 1T17
Apresentação 1T17Apresentação 1T17
Apresentação 1T17
CCR Relações com Investidores
 
Presentation 4Q16
Presentation 4Q16   Presentation 4Q16
Apresentação 4 t16
Apresentação 4 t16  Apresentação 4 t16
Apresentação 4 t16
CCR Relações com Investidores
 

More from CCR Relações com Investidores (20)

CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18CCR PRESENTATION 4Q18
CCR PRESENTATION 4Q18
 
Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18Apresentação de Resultado- CCR 4T18
Apresentação de Resultado- CCR 4T18
 
Apresentação 2T18
Apresentação 2T18Apresentação 2T18
Apresentação 2T18
 
2Q18 Presentation
2Q18 Presentation2Q18 Presentation
2Q18 Presentation
 
1Q18 Presentation
1Q18 Presentation1Q18 Presentation
1Q18 Presentation
 
Apresentação 1T18
Apresentação 1T18Apresentação 1T18
Apresentação 1T18
 
4Q17 Earnings Presentation
4Q17 Earnings Presentation4Q17 Earnings Presentation
4Q17 Earnings Presentation
 
Apresentação 4T17
Apresentação 4T17Apresentação 4T17
Apresentação 4T17
 
CCR Day 13 Presentation
CCR Day 13 Presentation CCR Day 13 Presentation
CCR Day 13 Presentation
 
CCR Day 13
CCR Day 13 CCR Day 13
CCR Day 13
 
Presentation 3Q17
Presentation 3Q17  Presentation 3Q17
Presentation 3Q17
 
Apresentação 3T17
Apresentação 3T17Apresentação 3T17
Apresentação 3T17
 
Presentations 2Q17
Presentations 2Q17Presentations 2Q17
Presentations 2Q17
 
Apresentação 2T17
Apresentação 2T17Apresentação 2T17
Apresentação 2T17
 
Presentation 2Q17
Presentation 2Q17Presentation 2Q17
Presentation 2Q17
 
Apresentação 2 t17
Apresentação 2 t17Apresentação 2 t17
Apresentação 2 t17
 
Presentation 1Q17
Presentation 1Q17 Presentation 1Q17
Presentation 1Q17
 
Apresentação 1T17
Apresentação 1T17Apresentação 1T17
Apresentação 1T17
 
Presentation 4Q16
Presentation 4Q16   Presentation 4Q16
Presentation 4Q16
 
Apresentação 4 t16
Apresentação 4 t16  Apresentação 4 t16
Apresentação 4 t16
 

Apimec 3 q05 results

  • 2. Disclaimer This presentation contains certain statements that are neither reported financial results or other historical information. They are forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond CCR’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators, the Company's ability to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. CCR does not undertake any obligation to publicly release any revisions to these forward looking statements to reflect events or circumstances after the date of these 2
  • 3. Agenda Highlights Results Outlook 3
  • 5. Highlights Operating • Lower operating costs with higher margins Reversal • Reversal of fiscal contingencies provision of R$ 62.1 million 5
  • 6. Escolher Novos Caminhos Vencer Novos Desafios São Paulo, 18 de Novembro de 2005 6
  • 7. Choosing New Paths Winning New Challenges São Paulo, November 18, 2005 7
  • 9. 3Q05 Results R$ Million 3Q05 3Q04 Ch% 3Q05 e/VO Ch % Net Revenues 519.3 393.0 32.1% 432.3 10.0% Total Costs (290.4) (235.0) 23.6% (240.1) 2.2% EBIT 228.9 158.0 44.9% 192.2 21.7% EBIT Margin 44.1% 40.2% +3.9p.p. 44.5% +4.3p.p. Depreciation & Amortization 81.3 57.9 40.4% 59.8 3.3% EBITDA 310.2 215.9 43.7% 252.0 16.7% EBITDA Margin 59.7% 54.9% +4.8p.p 58.3% +3.4p.p Financial Result 47.9 (18.5) -359.4% 15.7 -184.9% Net Income 182.3 93.6 94.8% 137.1 46.5% ViaOeste, operations management and currency exchange determined one more excellent quarter. 9
  • 10. 9M05 Results R$ Million 9M05 9M04 ch % 9M05 eVO ch% Net Revenues 1,402.4 1,065.3 31.6% 1,211.3 13.7% Total Costs (830.3) (694.2) 19.6% (722.6) 4.1% EBIT 572.1 371.1 54.1% 488.7 31.7% EBIT Margin 40.8% 34.8% +6.0p.p. 40.3% +5.5p.p. Depreciation & Amortization 221.1 169.7 30.3% 178,2 5.0% EBITDA 793.2 540.8 46.7% 666.9 23.3% EBITDA Margin 56.6% 50.8% +5.8p.p. 55.0% +4.2p.p Financial Result (24.9) (124.6) -80.0% (13.7) -89.0% Net Income 347.9 166.0 109.5% 314.1 89.2% The same efficiency can be noticed in this first half results. 10
  • 11. Revenues Toll Revenues (R$ 000) 3Q05 3Q04 Ch(%) 9M05 9M04 Ch(%) Total 538,691 405,975 32.7% 1,454,976 1,100,324 32.2% % Total Revenues 96.4% 96.3% 96.4% 96.5% Other Revenues 3Q05 3Q04 var(%) 9M05 9M04 var(%) Total 14,771 10,362 42.5% 38,959 28,340 37.5% % Total Revenues 2,6% 2,5% 2,6% 2,5% Revenues from Payment Systems 3Q05 3Q04 var(%) 9M05 9M04 var(%) STP 5.538 5.070 9.2% 14.924 12.157 22.8% % Total Revenues 1.0% 1.2% 1.0% 1.1% Total 559,000 421,407 32.7% 1,508,859 1,140,821 32.3% Revenues Breakdown 2Q05 Toll Payment Methods ViaOeste Via Lagos 17% Electronic 35,6% 43,1% AutoBAn Ponte 4% 40% Cash 11% Rodonorte 64,4% 56,9% 26% NovaDutra 3Q04 3Q05 11
  • 12. Traffic Quarterly Evolution 3Q05 x 3Q04 – Evolution by Each Concession (Vehicle Equivalents – million) CCR: +19.6% E/VO: - 0.6% 77 65 60 60 64 55 5.1% 4.1% 3.8% NovaDutra RodoNorte Ponte 3T01 3T02 3T03 3T04 3T05 AutoBAn ViaLagos -0.5% ViaOeste -1.5% -7.0% Despite a high interest rates scenario, the business remained strong and solid. 12
  • 13. Traffic Nine Months Historical Evolution 9M05 x 9M04 – Evolution by Each Concession (Vehicle Equivalents – million) 220 CCR: +18,2% E/VO: +2,0% 186 190 169 171 159 8.1% 8.1% 0.5% Rodonorte Ponte AutoBAn NovaDutra ViaLagos -1.5% 9M01 9M02 9M03 9M04 9M05 -4.0% Despite a high interest rates scenario, the business remained strong and solid. 13
  • 14. Total Costs Total Costs as a % of Net Revenues Evolution 59,8% 55,9% 65,2% 59,2% 13% 16% 12% 15% 10% 11% 12% 13% 21% 21% 23% 22% 33% 23% 33% 24% 24% 27% 24% 26% 3Q04 3Q05 9M04 9M05 D&A Concession Costs Third Party services Payroll Other Total Costs = Cost of Services plus Administrative Expenses Operating efficiency will be focused by the Company 14
  • 15. Indebtedness Gross Net 1,467.4 1,268.7 1,184.1 1,213.6 80.5% 873.7 R$ (million) R$ (million) 69.3% 678.5 56.6% 1,62 1,05 1,20 3Q03 3Q04 3Q05 3Q03 3Q04 3Q05 Short Term Long Term In R$ Net Debt Net Debt / EBITDA Low leverage gives flexibility for a new growth step 15
  • 16. Indebtedness Source of Funding Long Term Debt Amortization Other (102.8% CDI) 415.6 BID / IFC (Libor + 4.5%) Debentures 13% 19% 254.7 (105% CDI) 209.1 10% 181.2 R$ (million) 88.1 22% 48.9 36% Debêntures (IGP-M + 9.5% - 11%) 2006 2007 2008 2009 2010 After 2010 BNDES (3 months) (TJLP + 5.0%) Diversified sources, long term and no maturity concentration. 16
  • 17. Capital Expenditures CAPEX (R$ MM) 1Q05 2Q05 3Q05 2005 (E) 2006(E) AutoBAn 6.9 18.0 33.1 168.6 178.6 NovaDutra 16.4 17.8 22.1 110.1 83.7 Rodonorte 3,7 9,9 23,9 53,5 10,3 Ponte 0.7 2.0 1.8 22.8 11.0 Via Lagos 0.1 0.3 1.7 10.6 2.8 ViaOeste 3.3 21.2 27.3 90.0 90.0 1 Other 0.7 1.2 0.9 16.9 17.5 Consolidated 31.9 70.4 110.8 472.5 393.9 Note: Fiscal Year 2005 (E) and 2006 (E) includes inflation adjustment of 8.0% and 7.0% respectively 1- Includes CCR, Actua, Engelog and STP. Foreseeability, a business distinguishing mark. Capital expenditures are clearly defined in contract. 17
  • 19. New Businesses New Federal Concessions New Concessions in the State of São Paulo Porto Alegre Metropolitan Pole Mexico Chile Brazil continues the main growth driver. However, CCR will look for other markets 19
  • 20. Investor Relations Ricardo Froes - CFO ricardo.froes@ccrnet.com.br Phone: 55 (11) 3048-5921 Arthur Piotto Filho - IR arthur.piotto@ccrnet.com.br Phone: 55 (11) 3048-5932 BOVESPA: CCRO3 Bloomberg: CCRO3 BZ Reuters: CCRO3.SA www.ccrnet.com.br invest@ccrnet.com.br 20